PATRICIA DAMRON -ROBINSON: Open Payments
NPI 1831343870 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,398 in 86 payments from 29 companies in 2025. Trend: 2023 $3,553 · 2024 $4,402 · 2025 $3,398
Food & beverage: $1,985Long term medical supply or device loan: $1,000Education: $413
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $1,114 |
| Janssen Biotech, Inc. | 8 | $378 |
| AstraZeneca Pharmaceuticals LP | 9 | $245 |
| E.R. Squibb & Sons, L.L.C. | 7 | $242 |
| PFIZER INC. | 5 | $161 |
| BeOne Medicines USA, Inc. | 1 | $149 |
| Daiichi Sankyo Inc. | 2 | $127 |
| Incyte Corporation | 4 | $126 |
| Celgene Corporation | 3 | $111 |
| Merck Sharp & Dohme LLC | 3 | $83 |
Products named: KISQALI, OPDIVO, ENHERTU, TEVIMBRA, TALVEY, DARZALEX, REBLOZYL, KEYTRUDA.
Industry payments across IN — which companies pay providers there.
